Giada Rotunno is a biotechnologist, currently researcher scientist at the University of Florence, Center of Research and Innovation of Myeloproliferative Neoplasms (CRIMM) directed by Professor AM Vannucchi. Dr. Rotunno graduated in Medical and Pharmaceutical Biotechnology in 2012 and obtained her PhD degree in Biomedical science in Experimental and Clinical Oncology at the University of Florence in 2015. Her main scientific interests concern hematological disorders with particular focus on myeloproliferative neoplasms (MPN). She is working since 2012 on the study of mutation complexity of chronic and acute myeloid neoplasms, contributing to the refinement of the risk stratification of patients with MPN. In these years, she developed the Next Generation Sequencing (NGS) techniques actually used at CRIMM center. Dr Rotunno published 45 papers on high-impact factor journals including Blood, Leukemia and other peer-reviewed journals on myeloid neoplasms.